Breakthrough in the management of visceral leishmaniasis

Journal of Association of Physicians of India

Volumn 51, Issue JUL, 2003, Pages 649-651

  Thakur, B B ^a  

^a SK Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; DRUG DERIVATIVE; MILTEFOSINE; PHOSPHORYLCHOLINE;

ANIMAL; DRUG COMBINATION; HUMAN; INDIA; LEISHMANIA DONOVANI; NOTE; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIPROTOZOAL AGENTS; DRUG THERAPY, COMBINATION; HUMANS; INDIA; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; PHOSPHORYLCHOLINE;

EID: 2842589353     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (2)

1. V Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans Royal Soc Trop Med Hygiene 2001;95:239-42.
2. Sangraula H, Sharma KK, Rijal S, Dwivedi S, Koirala S. Orally effective drugs for Kala-azar (Visceral Leishmaniasis) : Focus on Miltefosine and Sitamaquine. J Assoc Physicians of India 2003;51:686-690